EW
Edwards Lifesciences CorpCompany with tickers: EW
CIK
1099800
CUSIP
28176E108
Shares Outstanding
575,800,000
Website
https://www.edwards.com
Investor Relations
https://ir.edwards.com/overview/default.aspx
13F Activity (30d)
66 filings
12 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$500,000,000
as of 2026-02-28
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-03-31 YTD | $421,800,000 | 10-Q, filed 2026-05-06 |
| 2025-12-31 | $893,400,000 | 10-K, filed 2026-02-25 |
| 2024-12-31 | $1,159,400,000 | 10-K, filed 2026-02-25 |
| 2023-12-31 | $879,600,000 | 10-K, filed 2026-02-25 |
| 2022-12-31 | $1,727,100,000 | 10-K, filed 2025-02-28 |
| 2021-12-31 | $512,800,000 | 10-K, filed 2024-02-12 |
| 2020-12-31 | $625,400,000 | 10-K, filed 2023-02-13 |
| 2019-12-31 | $263,300,000 | 10-K, filed 2022-02-14 |
| 2018-12-31 | $795,500,000 | 10-K, filed 2021-02-12 |
| 2017-12-31 | $763,300,000 | 10-K, filed 2020-02-14 |
| 2016-12-31 | $662,300,000 | 10-K, filed 2019-02-15 |
| 2015-12-31 | $280,100,000 | 10-K, filed 2018-02-16 |
| 2014-12-31 | $300,900,000 | 10-K, filed 2017-02-17 |
| 2013-12-31 | $496,900,000 | 10-K, filed 2016-02-19 |
| 2012-12-31 | $344,100,000 | 10-K, filed 2015-02-20 |
| 2011-12-31 | $303,400,000 | 10-K, filed 2014-02-28 |
| 2010-12-31 | $200,000,000 | 10-K, filed 2013-02-28 |
| 2009-12-31 | $95,500,000 | 10-K, filed 2012-02-27 |
| 2008-12-31 | $306,500,000 | 10-K, filed 2011-02-28 |